author_facet Alexander, Louis
Zhang, Sharon
McAuliffe, Brian
Connors, David
Zhou, Nannon
Wang, Tao
Agler, Michele
Kadow, John
Lin, Pin-Fang
Alexander, Louis
Zhang, Sharon
McAuliffe, Brian
Connors, David
Zhou, Nannon
Wang, Tao
Agler, Michele
Kadow, John
Lin, Pin-Fang
author Alexander, Louis
Zhang, Sharon
McAuliffe, Brian
Connors, David
Zhou, Nannon
Wang, Tao
Agler, Michele
Kadow, John
Lin, Pin-Fang
spellingShingle Alexander, Louis
Zhang, Sharon
McAuliffe, Brian
Connors, David
Zhou, Nannon
Wang, Tao
Agler, Michele
Kadow, John
Lin, Pin-Fang
Antimicrobial Agents and Chemotherapy
Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
Infectious Diseases
Pharmacology (medical)
Pharmacology
author_sort alexander, louis
spelling Alexander, Louis Zhang, Sharon McAuliffe, Brian Connors, David Zhou, Nannon Wang, Tao Agler, Michele Kadow, John Lin, Pin-Fang 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.00494-09 <jats:title>ABSTRACT</jats:title><jats:p>Human immunodeficiency virus type 1 (HIV-1) envelope (Env) binding induces proapoptotic signals in CD4<jats:sup>+</jats:sup>T cells without a requirement of infection. Defective virus particles, which represent the majority of HIV-1, usually contain a functional Env and therefore represent a potentially significant cause of such CD4<jats:sup>+</jats:sup>-T-cell loss. We reasoned that an HIV-1 inhibitor that prohibits Env-host cell interactions could block the destructive effects of defective particles. HIV-1 attachment inhibitors (AIs), which potently inhibit Env-CD4 binding and subsequent downstream effects of Env, display low-nanomolar antiapoptotic potency and prevent CD4<jats:sup>+</jats:sup>-T-cell depletion from mixed lymphocyte cultures, also with low-nanomolar potency. Specific Env amino acid changes that confer resistance to AI antientry activity eliminate AI antiapoptotic effects. We observed that CD4<jats:sup>+</jats:sup>-T-cell destruction is specific for CXCR4-utilizing HIV-1 strains and that the fusion blocker enfuvirtide inhibits Env-mediated CD4<jats:sup>+</jats:sup>-T-cell killing but is substantially less potent than AIs. These observations, in conjunction with observed antiapoptotic activities of soluble CD4 and the CXCR4 blocker AMD3100, suggest that this AI activity functions through a mechanism common to AI antientry activity, e.g., prevention of Env conformation changes necessary for specific interactions with cellular factors that facilitate viral entry. Our study suggests that AIs, in addition to having potent antientry activity, could contribute to immune system homeostasis in individuals infected with HIV-1 that can engage CXCR4, thereby mitigating the increased risk of adverse clinical events observed in such individuals on current antiretroviral regimens.</jats:p> Inhibition of Envelope-Mediated CD4<sup>+</sup>-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors Antimicrobial Agents and Chemotherapy
doi_str_mv 10.1128/aac.00494-09
facet_avail Online
Free
finc_class_facet Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDA0OTQtMDk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDA0OTQtMDk
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint American Society for Microbiology, 2009
imprint_str_mv American Society for Microbiology, 2009
issn 0066-4804
1098-6596
issn_str_mv 0066-4804
1098-6596
language English
mega_collection American Society for Microbiology (CrossRef)
match_str alexander2009inhibitionofenvelopemediatedcd4tcelldepletionbyhumanimmunodeficiencyvirusattachmentinhibitors
publishDateSort 2009
publisher American Society for Microbiology
recordtype ai
record_format ai
series Antimicrobial Agents and Chemotherapy
source_id 49
title Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_unstemmed Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_full Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_fullStr Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_full_unstemmed Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_short Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_sort inhibition of envelope-mediated cd4<sup>+</sup>-t-cell depletion by human immunodeficiency virus attachment inhibitors
topic Infectious Diseases
Pharmacology (medical)
Pharmacology
url http://dx.doi.org/10.1128/aac.00494-09
publishDate 2009
physical 4726-4732
description <jats:title>ABSTRACT</jats:title><jats:p>Human immunodeficiency virus type 1 (HIV-1) envelope (Env) binding induces proapoptotic signals in CD4<jats:sup>+</jats:sup>T cells without a requirement of infection. Defective virus particles, which represent the majority of HIV-1, usually contain a functional Env and therefore represent a potentially significant cause of such CD4<jats:sup>+</jats:sup>-T-cell loss. We reasoned that an HIV-1 inhibitor that prohibits Env-host cell interactions could block the destructive effects of defective particles. HIV-1 attachment inhibitors (AIs), which potently inhibit Env-CD4 binding and subsequent downstream effects of Env, display low-nanomolar antiapoptotic potency and prevent CD4<jats:sup>+</jats:sup>-T-cell depletion from mixed lymphocyte cultures, also with low-nanomolar potency. Specific Env amino acid changes that confer resistance to AI antientry activity eliminate AI antiapoptotic effects. We observed that CD4<jats:sup>+</jats:sup>-T-cell destruction is specific for CXCR4-utilizing HIV-1 strains and that the fusion blocker enfuvirtide inhibits Env-mediated CD4<jats:sup>+</jats:sup>-T-cell killing but is substantially less potent than AIs. These observations, in conjunction with observed antiapoptotic activities of soluble CD4 and the CXCR4 blocker AMD3100, suggest that this AI activity functions through a mechanism common to AI antientry activity, e.g., prevention of Env conformation changes necessary for specific interactions with cellular factors that facilitate viral entry. Our study suggests that AIs, in addition to having potent antientry activity, could contribute to immune system homeostasis in individuals infected with HIV-1 that can engage CXCR4, thereby mitigating the increased risk of adverse clinical events observed in such individuals on current antiretroviral regimens.</jats:p>
container_issue 11
container_start_page 4726
container_title Antimicrobial Agents and Chemotherapy
container_volume 53
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340330170810376
geogr_code not assigned
last_indexed 2024-03-01T16:02:15.019Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Inhibition+of+Envelope-Mediated+CD4%2B-T-Cell+Depletion+by+Human+Immunodeficiency+Virus+Attachment+Inhibitors&rft.date=2009-11-01&genre=article&issn=1098-6596&volume=53&issue=11&spage=4726&epage=4732&pages=4726-4732&jtitle=Antimicrobial+Agents+and+Chemotherapy&atitle=Inhibition+of+Envelope-Mediated+CD4%3Csup%3E%2B%3C%2Fsup%3E-T-Cell+Depletion+by+Human+Immunodeficiency+Virus+Attachment+Inhibitors&aulast=Lin&aufirst=Pin-Fang&rft_id=info%3Adoi%2F10.1128%2Faac.00494-09&rft.language%5B0%5D=eng
SOLR
_version_ 1792340330170810376
author Alexander, Louis, Zhang, Sharon, McAuliffe, Brian, Connors, David, Zhou, Nannon, Wang, Tao, Agler, Michele, Kadow, John, Lin, Pin-Fang
author_facet Alexander, Louis, Zhang, Sharon, McAuliffe, Brian, Connors, David, Zhou, Nannon, Wang, Tao, Agler, Michele, Kadow, John, Lin, Pin-Fang, Alexander, Louis, Zhang, Sharon, McAuliffe, Brian, Connors, David, Zhou, Nannon, Wang, Tao, Agler, Michele, Kadow, John, Lin, Pin-Fang
author_sort alexander, louis
container_issue 11
container_start_page 4726
container_title Antimicrobial Agents and Chemotherapy
container_volume 53
description <jats:title>ABSTRACT</jats:title><jats:p>Human immunodeficiency virus type 1 (HIV-1) envelope (Env) binding induces proapoptotic signals in CD4<jats:sup>+</jats:sup>T cells without a requirement of infection. Defective virus particles, which represent the majority of HIV-1, usually contain a functional Env and therefore represent a potentially significant cause of such CD4<jats:sup>+</jats:sup>-T-cell loss. We reasoned that an HIV-1 inhibitor that prohibits Env-host cell interactions could block the destructive effects of defective particles. HIV-1 attachment inhibitors (AIs), which potently inhibit Env-CD4 binding and subsequent downstream effects of Env, display low-nanomolar antiapoptotic potency and prevent CD4<jats:sup>+</jats:sup>-T-cell depletion from mixed lymphocyte cultures, also with low-nanomolar potency. Specific Env amino acid changes that confer resistance to AI antientry activity eliminate AI antiapoptotic effects. We observed that CD4<jats:sup>+</jats:sup>-T-cell destruction is specific for CXCR4-utilizing HIV-1 strains and that the fusion blocker enfuvirtide inhibits Env-mediated CD4<jats:sup>+</jats:sup>-T-cell killing but is substantially less potent than AIs. These observations, in conjunction with observed antiapoptotic activities of soluble CD4 and the CXCR4 blocker AMD3100, suggest that this AI activity functions through a mechanism common to AI antientry activity, e.g., prevention of Env conformation changes necessary for specific interactions with cellular factors that facilitate viral entry. Our study suggests that AIs, in addition to having potent antientry activity, could contribute to immune system homeostasis in individuals infected with HIV-1 that can engage CXCR4, thereby mitigating the increased risk of adverse clinical events observed in such individuals on current antiretroviral regimens.</jats:p>
doi_str_mv 10.1128/aac.00494-09
facet_avail Online, Free
finc_class_facet Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9hYWMuMDA0OTQtMDk
imprint American Society for Microbiology, 2009
imprint_str_mv American Society for Microbiology, 2009
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 0066-4804, 1098-6596
issn_str_mv 0066-4804, 1098-6596
language English
last_indexed 2024-03-01T16:02:15.019Z
match_str alexander2009inhibitionofenvelopemediatedcd4tcelldepletionbyhumanimmunodeficiencyvirusattachmentinhibitors
mega_collection American Society for Microbiology (CrossRef)
physical 4726-4732
publishDate 2009
publishDateSort 2009
publisher American Society for Microbiology
record_format ai
recordtype ai
series Antimicrobial Agents and Chemotherapy
source_id 49
spelling Alexander, Louis Zhang, Sharon McAuliffe, Brian Connors, David Zhou, Nannon Wang, Tao Agler, Michele Kadow, John Lin, Pin-Fang 0066-4804 1098-6596 American Society for Microbiology Infectious Diseases Pharmacology (medical) Pharmacology http://dx.doi.org/10.1128/aac.00494-09 <jats:title>ABSTRACT</jats:title><jats:p>Human immunodeficiency virus type 1 (HIV-1) envelope (Env) binding induces proapoptotic signals in CD4<jats:sup>+</jats:sup>T cells without a requirement of infection. Defective virus particles, which represent the majority of HIV-1, usually contain a functional Env and therefore represent a potentially significant cause of such CD4<jats:sup>+</jats:sup>-T-cell loss. We reasoned that an HIV-1 inhibitor that prohibits Env-host cell interactions could block the destructive effects of defective particles. HIV-1 attachment inhibitors (AIs), which potently inhibit Env-CD4 binding and subsequent downstream effects of Env, display low-nanomolar antiapoptotic potency and prevent CD4<jats:sup>+</jats:sup>-T-cell depletion from mixed lymphocyte cultures, also with low-nanomolar potency. Specific Env amino acid changes that confer resistance to AI antientry activity eliminate AI antiapoptotic effects. We observed that CD4<jats:sup>+</jats:sup>-T-cell destruction is specific for CXCR4-utilizing HIV-1 strains and that the fusion blocker enfuvirtide inhibits Env-mediated CD4<jats:sup>+</jats:sup>-T-cell killing but is substantially less potent than AIs. These observations, in conjunction with observed antiapoptotic activities of soluble CD4 and the CXCR4 blocker AMD3100, suggest that this AI activity functions through a mechanism common to AI antientry activity, e.g., prevention of Env conformation changes necessary for specific interactions with cellular factors that facilitate viral entry. Our study suggests that AIs, in addition to having potent antientry activity, could contribute to immune system homeostasis in individuals infected with HIV-1 that can engage CXCR4, thereby mitigating the increased risk of adverse clinical events observed in such individuals on current antiretroviral regimens.</jats:p> Inhibition of Envelope-Mediated CD4<sup>+</sup>-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors Antimicrobial Agents and Chemotherapy
spellingShingle Alexander, Louis, Zhang, Sharon, McAuliffe, Brian, Connors, David, Zhou, Nannon, Wang, Tao, Agler, Michele, Kadow, John, Lin, Pin-Fang, Antimicrobial Agents and Chemotherapy, Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors, Infectious Diseases, Pharmacology (medical), Pharmacology
title Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_full Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_fullStr Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_full_unstemmed Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_short Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
title_sort inhibition of envelope-mediated cd4<sup>+</sup>-t-cell depletion by human immunodeficiency virus attachment inhibitors
title_unstemmed Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors
topic Infectious Diseases, Pharmacology (medical), Pharmacology
url http://dx.doi.org/10.1128/aac.00494-09